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Introduction
The structure of tissues is preserved by mechanisms that en-
sure the maintenance of the stem cell (SC) and progenitor cell 
compartments. These mechanisms are often altered in cancer 
(van de Wetering et al., 2002; Fre et al., 2005; Blanpain et al., 
2006; Bouras et al., 2008; Karamboulas and Ailles, 2013). The 
homeostasis of several normal SC compartments rests on the 
ability of SCs to perform asymmetric self-renewing divisions in 
which one of the two daughter cells (DCs) retains the SC fate 
and withdraws into quiescence, whereas the other assumes a 
progenitor fate characterized by mitotic expansion and subse-
quent terminal differentiation (Lechler and Fuchs, 2005; Shinin 
et al., 2006; Bello et al., 2008; Bowman et al., 2008; Knoblich, 
2010). This ensures the production of a large number of dif-
ferentiated cells while limiting the size of the SC pool, and it 
likely represents a mechanism of tumor suppression. This latter 
notion is supported by evidence showing that skewing of the 
replicative mode from an asymmetric to a symmetric one (one 
SC → two SCs) is associated with tumorigenesis (Caussinus 
and Gonzalez, 2005; Cicalese et al., 2009).
Mechanisms underpinning asymmetric division rely on 
the unequal positioning of the two progeny relative to external 
cues (the “niche” concept) and/or on asymmetric partitioning 
of cell fate determinants during SC mitosis (Rhyu et al., 1994; 
Spana et al., 1995; Zhong et al., 1996; Lechler and Fuchs, 2005; 
Morrison and Kimble, 2006). In this second mechanism, a pro-
tein called Numb plays a critical role. By partitioning differen-
tially between the two DCs, Numb controls their fate (Uemura 
et al., 1989; Rhyu et al., 1994; Zhong et al., 1996; Pece et al., 
2011). The action of Numb has been attributed to its ability to 
antagonize the surface receptor Notch (Guo et al., 1996; Spana 
and Doe, 1996; McGill and McGlade, 2003; Pece et al., 2011). 
However, Numb is also able to stabilize p53 by interfering with 
its Mdm2-dependent ubiquitination and degradation (Colaluca 
et al., 2008). This might be relevant to SC homeostasis, be-
cause in isolated mammary stem cells, p53 imposes an asym-
metric mode of self-renewal (Cicalese et al., 2009). Thus, the 
Numb-p53 axis might function as a tumor-suppressor pathway: 
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Numb asymmetric partitioning at mitosis could cause func-
tional asymmetry of the Numb-p53 circuitry that would impart 
distinct developmental and proliferative fates to the two DCs.
Indeed, Numb expression is frequently attenuated in 
tumors (Pece et al., 2004; Colaluca et al., 2008; Westhoff et 
al., 2009). In breast cancers, one third of all tumors are Numb 
deficient, an event that correlates with aggressive disease and 
poor prognosis (Pece et al., 2004; Colaluca et al., 2008). Loss 
of Numb expression might well represent a major mechanism 
to override p53-mediated tumor suppression in these cancers, 
in which p53 mutations are relatively infrequent (Pharoah et 
al., 1999), by causing a reduction in p53 activity and skew-
ing self-replicative divisions from an asymmetric to a sym-
metric mode. If so, the restoration of the Numb-p53 axis in 
Numb-deficient tumors should constitute an effective SC- 
targeted therapy. Finally, the predominant distribution of Numb 
in the luminal, as compared with the myoepithelial, layer of the 
normal mammary gland (Pece et al., 2004), argues that Numb 
might exert a role also in the control of progenitor maturation 
and terminal differentiation. The present study was undertaken 
to test these hypotheses.
Results
Numb partitions asymmetrically at the 
mitosis of PKHhigh cells
By using the PKH (named for its discoverer, Paul Karl Horan)
methodology combined with the mammosphere (MS) culture 
assay (Cicalese et al., 2009; Pece et al., 2010; Fig. S1, A–D), we 
have previously described the purification of a small population 
of cells (henceforth PKHhigh cells) from the human or the mu-
rine mammary gland that display the characteristics expected of 
SCs. In these cells, Numb partitions unequally during mitosis 
(Cicalese et al., 2009; Pece et al., 2010; Fig. 1, A and B). To 
verify whether Numb segregates into the DC that retains SC-
like properties or into the DC that displays progenitor-like be-
havior, mouse PKHhigh cells from first-generation MS (see Fig. 
S1, E and F for a characterization of MS) were transduced with 
a lentiviral vector encoding Numb fused to the DsRed protein 
(DsRed-Numb) and monitored by time-lapse video microscopy. 
The mode of division was established by two criteria (Fig. 1 C 
and Materials and methods). (1) An initial asymmetric division 
of the PKHhigh cell, followed by symmetric divisions of the pro-
genitor, led to a typical 1–2-3-5 progression in the cell number; 
conversely, an initial symmetric division of the PKHhigh cell led 
to a 1–2-4 pattern. (2) Retrospectively, the DC that retained 
SC-like characteristics was identified as the cell that remained 
quiescent and retained the PKH dye, whereas the progenitor di-
vided further to yield a dull progeny; this pattern was clearly 
identifiable only when an initial asymmetric division had oc-
curred, because a fully symmetric pattern of division led to pro-
gressive dilution of the dye. We found that PKHhigh cells divided 
mainly asymmetrically and that Numb partitioned into the DC 
that retained SC-like characteristics (Fig. 1 D).
To guard against potential artifacts caused by excessive 
Numb-DsRed expression, we developed a more physiological 
setting based on the ablation of endogenous Numb followed 
by ectopic expression of Numb-DsRed under the control of a 
minimal cytomegalovirus (CMV) promoter (mCMV-Numb). 
To do this, cells dissociated from normal MS were transduced 
with an sh-oligo (sh-b; Fig. S2) to stably silence Numb and then 
transduced with mCMV-Numb or mock infected. This approach 
enabled reconstitution of Numb expression in Numb-knock-
down (Numb-KD) cells to a level similar to the physiological 
one (Fig. S1 G). Also under these conditions, Numb partitioned 
asymmetrically in the stem-like DC at the first division of 
PKHhigh cells (Fig. S1 H).
Numb expression in the mammary gland
To correlate these findings with the in vivo setting, we analyzed 
Numb distribution in the mouse mammary gland of 4-wk-old 
virgin females. This showed that, as observed in the normal 
human gland (Pece et al., 2004), Numb decorates the luminal 
epithelial layer of cytokeratin-8 (CK8)+ cells, whereas it is ex-
cluded or expressed at low levels in the basal/myoepithelial 
layer of p63+ cells (Fig.  2, A and B). Importantly, however, 
Numb was expressed in rare basal, p63+ cells (Fig. 2, A and B) 
that, when occasionally dividing, showed asymmetric distribu-
tion of Numb to one of the progeny (Fig. 2, B–D). Conversely, 
in dividing luminal cells, Numb segregation was predominantly 
symmetric (Fig. 2, B–D).
These results show that in the mammary gland in vivo, 
there are at least two populations of Numb-expressing cells: one 
corresponding to bona fide luminal cells, in which Numb par-
titions symmetrically at mitosis, and the other, constituted by 
rare basal p63+ cells present in the myoepithelial layer (which 
is in itself by and large Numb negative), in which Numb is 
asymmetrically segregated at mitosis similarly to what we ob-
served in PKHhigh cells.
To gain insight into the relationship between the two 
Numb-positive populations, we reverted to the ex vivo system 
and monitored Numb expression at different stages during MS 
formation. This revealed that, following the asymmetric parti-
tioning of Numb at the mitosis of PKHhigh cells, Numb is main-
tained at very low levels of expression in the early progeny 
(up to ∼4 d) and then progressively accumulates at later stages 
(Fig.  3, A–C), suggesting that, at least in vitro, Numb might 
exert a dual role in the PKHhigh cell and in progenitors.
Numb controls asymmetric self-renewal in 
an ex vivo system
To investigate this possibility, we analyzed the consequences 
of Numb ablation. Because cytokeratin-5 (CK5) is a well-es-
tablished basal layer marker (Shackleton et al., 2006; Stingl et 
al., 2006; Cicalese et al., 2009; Pece et al., 2010), we crossed 
Cre-loxP conditional Numb-knockout (Numb-KO) mice (Zilian 
et al., 2001; Wilson et al., 2007) with CK5-Cre mice (Ramirez 
et al., 2004). Primary mammary epithelial cells (MECs) estab-
lished from these mice, and MS formed by them, displayed 
(a) markedly reduced Numb levels (Fig. 4 A), (b) decreased p53 
levels and congruent alterations of positively (mdm2 and p21) 
and negatively regulated (nanog) p53 targets (Fig. 4, A and B), 
and (c) enhanced Notch activity measured by transcription of 
the Notch targets hey1 and hey2 (Fig. 4 B).
MS from wild-type (WT) MECs contained ∼300 cells/
MS, with a sphere-forming efficiency (SFE) of ∼0.4% 
(Fig. 4 C). Thus, the frequency of MS forming units (MFUs) 
in WT-MS was ∼1:300, in agreement with previous reports 
(Cicalese et al., 2009). MS from Numb-KO MECs were ap-
proximately twofold larger (∼500 cells/MS) and showed an 
approximately twofold to threefold higher SFE, with an esti-
mated frequency of ∼4–5 MFUs per MS (Fig. 4 C). Upon serial 
propagation, WT-MS progressively lost self-renewal ability 
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(Fig.  4  D), consistent with previous reports (Cicalese et al., 
2009; Pece et al., 2010). Conversely, the number of Numb-KO 
MS increased over time, with a constant approximately two-
fold to threefold expansion rate (Fig. 4 D). Finally, during the 
formation of MS, Numb-KO cells divided predominantly in a 
symmetric fashion, and with a faster division rate compared 
with WT cells (Fig. 4 E). The entire set of observations was 
replicated using functional ablation (KD) of Numb in WT-
MECs (Fig. S2). These observations argue that, at least in the 
ex vivo system herein used, Numb controls asymmetric self- 
renewal and lifespan of PKHhigh cells, thus safeguarding against 
their uncontrolled expansion.
Numb controls p53 activity in PKHhigh cells
We investigated the mechanisms through which Numb controls 
the fate of the progeny of PKHhigh cells. We have previously 
shown that (a) the ratio of symmetric versus asymmetric di-
visions in PKHhigh cells is controlled by p53 (Cicalese et al., 
2009), and (b) Numb stabilizes the levels of p53 (Colaluca et 
al., 2008). Thus, because Numb partitions in the DC that retains 
stem-like features, it might function by positively modulating 
p53 activity in that cell. To investigate p53 activity, we used 
a p53 reporter containing multiple p53-binding sites upstream 
of a minimal CMV promoter to drive the expression of an un-
stable GFP protein (uGFP; half-life of ∼60 min; Insinga et al., 
Figure 1. Numb in the mitotic division of PKHhigh cells. (A) PKHhigh cells (Fig. S1, A–D) were mock-treated (right) or treated with blebbistatin (left), which, 
by blocking cytokinesis (Straight et al., 2003), permits a better visualization of the endogenous Numb crescent at the plasma membrane, and stained 
with anti-Numb Ab and DAPI (blue). Bar, 5 µm. (B) Numb distribution in the three PKH fractions purified from MS (∼100 cells analyzed per fraction). 
*, P < 0.05 versus the comparable condition (symmetric or asymmetric) in PKHhigh. (C) Schematic of the methodology used to retrospectively assign cellular 
identity and mode of division; details are in Materials and methods. (D, left) Numb-DsRed–infected MS were dissociated, PKH-labeled (PKH488, green), 
and analyzed by video microscopy. Elapsed time is indicated. Arrowheads point to the stem-like DC. Bar, 10 µm. (right) Quantification of the divisional 
histories of PKH-labeled cells (top) and of the partition of Numb into the stem-like DC (bottom). The bar “Numb not in stem-DC” indicates Numb partitioned 
into the progenitor-DC or equally partitioned between the two daughters. *, P < 0.05.
 o
n






Published November 23, 2015
JCB • Volume 211 • NumBer 4 • 2015848
2013). Cells from control (Ctr; mock silenced) or Numb-KD 
MSs were transduced with the p53-uGFP reporter, labeled with 
PKH, and allowed to reform MSs. Second-generation MSs were 
FACS purified, yielding a PKHhigh (enriched in cells with SC-
like characteristics) and a PKHneg (enriched in progenitor-like 
cells) fraction (Cicalese et al., 2009; Pece et al., 2010). In Ctr 
populations, the p53-uGFP reporter activity was approximately 
twofold higher in PKHhigh cells than in PKHneg cells (Fig. 5 A, 
left), as also confirmed by direct detection of p53 protein lev-
els (Fig. S3 A). Compared with Ctr-PKHhigh cells, KD-PKH-
high cells showed approximately threefold lower overall levels 
of p53 activity (Fig.  5 A, right). Finally, we established that, 
during the initial phases of formation of a MS, p53 activity seg-
regated with the PKHhigh cell (Fig. 5 B) and cosegregated with 
Numb (Fig. 5 C). In Ctr-PKHhigh cells, at the time of the first 
division, p53 activity was equally partitioned between the two 
DCs. Subsequently, however, the DC that retained stem-like 
properties reaccumulated high p53 activity levels, whereas the 
progenitor did not (Fig. 5 D). The accumulation of p53 activity 
was Numb dependent. Indeed, in Numb-KD PKHhigh cells, there 
were overall lower levels of p53 activity and no evident signs 
of an increase in p53 activity in either DC (Fig.  5  E). These 
findings argue that the unequal partitioning of Numb at mitosis 
of PKHhigh cells is reflected into a functional asymmetry of p53 
Figure 2. Numb in the normal mouse mammary gland. (A) Multichannel IF analysis of a murine mammary gland FFPE section using the indicated markers. 
The boxed area, in the top panel, is magnified in the bottom panels (mag.), with individual channels for each marker. The arrowhead points to a basal, 
p63+ cell expressing Numb (further magnified in the insets). CK8, white; p63, red; Numb, green; DAPI, blue. Bars: (top) 50 µm; (magnification and inset) 
10 µm. (B) IF analysis of 4-wk-old mammary gland FFPE serial sections using the indicated markers (see Materials and methods for details). Three different 
alveoli are shown. The boxed areas indicate dividing cells (magnified below in C; four cells are boxed: three basal cells, boxed with a continuous line, 
and one luminal cell, boxed with a dashed line) in the luminal (CK8+) or in the basal (p63+) layer expressing the mitotic marker phosphorylated histone 3 
(P-H3). P-H3, white; CK8, red; p63, red; Numb, green; DAPI, blue. The consecutive (cons.) section is indicated. Bar, 50 µm. (C) Magnifications of boxed 
areas in B. Top three rows (basal) show mitotic basal cells (see alveoli 1–3 in B) with asymmetric Numb crescent (dashed line). The cleavage plane (solid 
line) was deduced from the positions of the centrosomes. Note the diffuse cytoplasmic staining of p63 due to disassembly of the nuclear envelope. Bottom 
row (luminal) shows symmetric Numb crescents (dashed lines) during mitosis of a luminal, CK8+/p63− cell (see alveolus 3 in B). The consecutive (cons.) 
section is indicated. Bar, 10 µm. (D) Quantification of the experiment shown in B, displaying the frequency of Numb asymmetric/symmetric events in the 
indicated number of basal and luminal cells. *, P < 0.05 versus matched condition. Error bars are 95% confidence intervals.
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activity, likely required to control asymmetric self-renewal, at 
least under the ex vivo conditions herein used.
Restoration of p53 rescues the effects of 
Numb ablation
We used Nutlin3, an inhibitor of p53 ubiquitination/degradation 
(Vassilev et al., 2004), to test whether the restoration of p53 
activity in Numb-KD cells could restore replicative asymme-
try. Nutlin3 induced a dose-dependent increase of p53 expres-
sion in cells from dissociated Numb-KD MS (Fig. 6 A). This 
was accompanied by a reduction in the number and average 
size of Numb-KD MS, but not of Ctr MS (Fig. 6 B). Nutlin3 
also impaired the ability of Numb-KD MS to expand in culture 
(Fig. 6 C) and caused a significant increase in asymmetric di-
visions (Fig. 6 D). The entire set of data obtained in Numb-KD 
cells was replicated in Numb-KO cells (selected experiments 
are in Fig. S3, B–D; a more detailed account is in Fig.  10). 
We could also demonstrate that (a) at the highest concentra-
tion used in our experiments (10  µM), Nutlin3 did not exert 
any apparent general antiproliferative or proapoptotic effect 
(Fig. S3 B), and (b) the effects of Nutlin3 were specific, as wit-
nessed by experiments performed with an inactive enantiomer, 
Nutlin3b (Fig. S3, C and D).
Loss of Numb reprograms progenitors and 
differentiated cells to a SC-like state
Although the aforementioned findings define a role for Numb 
in PKHhigh cells, the observations that Numb is increasingly ex-
pressed in proliferating progenitors (Fig. 3) and that it decorates 
the luminal layer in the adult gland (Fig. 2, A and B; Pece et al., 
2004) argue for a role of Numb also at the level of progenitors 
and differentiated cells.
To analyze the consequences of Numb dysfunction at this 
level, we used a well-established protocol for immunopheno-
typical purification of various epithelial components from the 
mammary gland (Asselin-Labat et al., 2007; Guo et al., 2012). 
This protocol exploits the surface antigens CD49F and CD61 
(Asselin-Labat et al., 2007; Guo et al., 2012) and allows the iso-
lation of three populations: (1) basal cells (CD49Fhigh/CD61+, 
enriched in SCs and also containing myoepithelial cells), (2) 
luminal progenitors (CD49Flow/CD61+), and (3) differentiated 
luminal cells (CD49Flow/CD61−; Fig. 7 A and Fig. S4 A). When 
the purification was performed in parallel in WT and KO glands, 
we observed, in the latter, increased frequency of SC-enriched 
basal cells and of immature luminal progenitors and a decrease 
in differentiated luminal cells (Fig. 7 B). This result suggests a 
role for Numb in maturation and luminal specification of pro-
genitors. Thus, we used the CD49F/CD61 purification protocol 
and performed Numb silencing in the three populations to test 
them for self-renewal ability in MS serial propagation assays 
and for organotypic ability in 3D-Matrigel assays. 3D Matrigel 
outgrowths were also used as a source of cells for mammary fat 
pad reconstitution experiments in vivo. In SC-enriched basal 
cells, Numb ablation resulted in (a) increased MS-forming effi-
ciency and self-renewal ability, compatible with a skewing from 
an asymmetric to a symmetric mode of division (Fig. 7 C); and 
(b) increased repopulation efficiency of the mammary fat pad 
in vivo (Fig. 7 D). In luminal progenitors and in terminally dif-
ferentiated cells, Numb ablation resulted in the de novo acqui-
sition of self-renewal potential in vitro (Fig. 7 C) and in vivo 
Figure 3. Numb in progenitors. (A) Numb-KD MS, reconstituted with mCMV-Numb, were dissociated and analyzed by video microscopy. (left) Frames of 
a typical tracking experiment are shown. Dashed lines identify the cellular identity (stem or P, progenitors, numbered 1–5 according to the order of appear-
ance). Bar, 10 µm. (middle) Quantification of the experiment. Individual trend lines represent the integrated density calculated in each cell, as indicated. The 
trend line for P 5 is minimal, as this cell appeared at the end of the recording. (right) The mean trend lines represent the mean integrated Numb levels of all 
progenitors, shown in comparison to that of the stem cell (n = 3 videos from a single experiment). (B) The pattern of endogenous Numb distribution was an-
alyzed in PKH-labeled WT MSs at different stages of formation by IF. Bar, 10 µm. Dotted lines, PKHhigh cells. (C) Cells from 4- and 7-d MSs were FACS-sorted 
based on their PKH content and analyzed by IF. For Numb in PKHneg cells from 7-d MSs (bottom panels), two representative images are shown to indicate 
that Numb expression in late progenitors is heterogeneous. Bar, 10 µm. Quantifications are shown in the rightmost panels. *, P < 0.05 versus PKHhigh.
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(Fig. 7 D). In all cases, transplantation of the Numb-KD pop-
ulations yielded the formation of tumors, a finding that will be 
analyzed in depth later.
The organotypic 3D-Matrigel assays further revealed, in 
keeping with previous studies (Shackleton et al., 2006; Stingl 
et al., 2006), that (a) in MECs from the unperturbed mammary 
gland, basal cells with SC characteristics, present in the basal/
myoepithelial fraction, generated filled-type structures; (b) 
progenitors formed hollow-type structures; and (c) differenti-
ated luminal cells were devoid of organogenetic ability (Fig. 7, 
E and F; and Fig. S4 B). When KD populations were tested, 
we noticed (a) increased efficiency of formation of filled-type 
structures by basal MECs, (b) appearance of filled-type struc-
tures generated by KD progenitors, and (c) acquisition of de 
novo organogenetic ability by terminally differentiated cells, 
which formed both filled and hollow structures (Fig. 7, E and 
F; and Fig. S4 B). It is of note that the formation of disorga-
nized, filled and hyperproliferative structures in 3D-Matrigel 
assays, besides being a typical phenotype of true SCs, is also 
associated with luminal progenitors that have undergone dedif-
ferentiation and acquired stemness traits through the epithelial-to- 
mesenchymal transition (EMT; Mani et al., 2008; Guo et al., 
2012). Consistent with this, we observed that depletion of Numb 
in the three FACS-sorted populations of SC-enriched basal 
cells, luminal progenitors, and luminal differentiated cells re-
sulted in enhanced expression of EMT-associated transcription 
factors, evidenced both at the mRNA and protein levels (Fig. 7, 
G and H; and Fig. S4 C). Similar results were also obtained in 
Figure 4. Numb controls the replicative mode during MS formation. (A) WT and Numb-KO (KO1 and KO2; see Fig. 9 for details) MECs or MS were 
analyzed by IB. (B) The indicated cells were analyzed by quantitative PCR. Data are from a single experiment run in triplicate and expressed relative to 
mRNA levels in WT cells (=1). Nan., nanog. (C, left) Representative images of WT and Numb-KO MS. Bar, 100 µm. Right, SFE and size (Cells/sphere) 
of WT and Numb-KO MS. (D) Cumulative sphere and cell number (nr.) from serial replating of WT and Numb-KO MS. A single representative experiment 
out of two repeats is shown. (E, left) Representative time-lapse video microscopy of the formation of WT or KO MS. Bar, 10 µm. (right) Quantification of 
the experiment. The mode and the time of the first division are shown. *, P < 0.05 versus comparable WT condition.
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unfractionated Numb-KD MECs (Fig. S4 D). In this setting, a 
typical EMT transcriptional pattern could be reverted by ecto-
pically expressed Numb-DsRed or by treatment with Nutlin3 
(Fig. S4 D), pointing to the mechanistic implication of the 
Numb/p53 circuitry dysfunction in the occurrence of EMT.
These results argue that, at least under the ex vivo con-
ditions of analysis herein used, Numb exerts a role at the pro-
genitor compartment level, where Numb appears to suppress 
EMT and to ensure proper maturation and luminal cell fate 
specification. The results also demonstrate that loss of Numb 
reprograms, likely through EMT, progenitors and differen-
tiated luminal cells to a SC-like state, eventually associated 
to tumorigenic potential.
Loss of Numb associates with aberrant 
mammary morphogenesis in vivo
These findings prompted us to evaluate the mammary gland 
of Numb-KO female mice. We initially analyzed the organo-
genetic ability of Numb-KO MECs, compared with WT, in 
3D-Matrigel assays. The outgrowths generated by Numb-KO 
MECs displayed features of faulty morphogenesis, with disor-
ganized, filled, and hyperproliferative structures, as opposed 
to the hollow-type acinar structures generated by WT MECs 
(Fig. 8, A and B). Consistent with this, histological analysis of 
12-wk-old Numb-KO mammary glands invariably revealed, in 
comparison with WT glands, traits of aberrant morphogenesis, 
with gross morphological alterations consisting in ductal hyper-
plasia and ectasia, supernumerary lateral branching, and with 
the presence of areas of severe dysplasia, including hyperplastic 
alveolar nodules (HANs), which represent typical preneoplas-
tic lesions (Medina, 1988; Skolnick et al., 1990; Jerry et al., 
1993; Cardiff et al., 2000; Fig. 8, C–E). The Numb-KO mice, 
however, did not develop overt tumors, suggesting the need for 
additional events to develop the fully transformed phenotype 
(see Discussion). Numb-KO glands also displayed signs of ab-
errant lineage specification such as a marked increase in cells 
Figure 5. Numb controls p53 activity. (A) p53 activity in Ctr PKHhigh and PKHneg cells (left), and in PKHhigh cells from Ctr or Numb-KD cells (right). Data 
are expressed as % of Ctr-PKHhigh cells. *, P < 0.05 versus Ctr-PKHhigh cells. (B and C) Cosegregation (Coseg.) of p53 activity (GFP) in PKHhigh cells (B) 
and in Numbhigh (Numb = Numb-DsRed) cells (C), during MS formation. Left panels, frames of a typical experiment. Right, quantifications; *, P < 0.05. 
(D) Fluorescence tracking of p53 activity (GFP) and PKH during the first and second divisions of WT (Ctr = mock-infected) PKHhigh cells. (left) A typical ex-
ample is shown. Bar, 10 µm. Right, quantifications. Individual best-fit lines represent the fluorescence intensity of SCs (n = 13) and progenitors (P, n = 13) 
between the first and second division. The “average best-fit” (rightmost) panel represents the mean of all SCs and P. *, P < 0.05. (E) Fluorescence tracking 
of p53 activity (GFP) and PKH during the first and second divisions of Numb-KD cells (n = 16, for a total of 32 tracks DC1 + DC2). Data are shown as in 
E. Because the two DCs of a Numb-KD PKHhigh cell are indistinguishable, we referred to them as DC.
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with concomitant expression of basal (CK14 or CD49F) and 
luminal (CK8) markers (Fig. 8 F and Fig. S4 E) and changes 
typically associated to EMT, such as decreased E-cadherin ex-
pression and increased frequency of cells positive for the tran-
scription factors Sox9 and Slug (Fig. 8 G). We also noticed the 
appearance of Slug+ cells outside the basal/myoepithelial layer, 
with the presence of cells showing concomitant Sox9 and Slug 
expression (Fig. 8 G), a trait associated with the de novo ac-
quisition of a SC state via EMT-dependent dedifferentiation of 
progenitors (Guo et al., 2012).
Thus, Numb dysfunction results in profound alterations 
of the mammary morphogenetic program, with the emer-
gence of signs of aberrant differentiation and the appearance 
of preneoplastic lesions.
Loss of Numb promotes tumorigenesis
Prompted by these results, we performed reconstitution experi-
ments in cleared mammary fat pads using MECs, or dissociated 
MS, from Numb-KO and WT mice. We observed approxi-
mately fivefold more SCs in KO-derived populations than 
in WT (Fig. 9, A and B).
At the morphological level, the outgrowths generated by 
WT MECs and dissociated WT MSs were indistinguishable from 
the normal gland (Fig.  9  C, top), whereas those generated by 
Numb-KO cells displayed gross morphological alterations. We 
transplanted ten lines of MECs (or MS) from Numb-KO mice. 
In 7 of 10 cases, the reconstituted mammary tissue appeared hy-
perdense and hyperbranched (as exemplified by KO2; Fig. 9 C, 
middle) and displayed hyperplastic/dysplastic and preneoplas-
tic lesions (HANs) and areas of frank malignancy (Fig. 9 D). In 
some cases (3 of 10), the outgrowths were overtly neoplastic (as 
exemplified by KO1; Fig. 9 C, bottom). The outcome of trans-
plantation was an intrinsic property of each line, as individual 
MEC lines consistently gave rise either to an altered hyperplastic/
dysplastic gland (always containing, however, malignant areas, 
e.g., KO2 in Fig. 9 C, middle) or to tumors (e.g., KO1 in Fig. 9 C, 
bottom). In all cases, the Numb-KO-driven expansion of the SC 
compartment was comparable, as witnessed by the similar effi-
ciency of repopulation by KO1 and KO2 cells (Fig. 9, A and B; 
and see Fig. S5, A–C, for similar results obtained with Numb-KD 
cells). Histology of Numb-KO tumors invariably revealed signs 
of poor differentiation and high aggressiveness, such as loss of 
estrogen-receptor and E-cadherin and high expression of the pro-
liferative marker PCNA (exemplified by KO1 in Fig. 9 E, left), 
accompanied by the presence of EMT traits (exemplified by 
KO1 in Fig. 9 E, right). The occurrence of EMT in these tumors 
was confirmed by the typical EMT transcriptional pattern dis-
played by Numb-KO MECs in vitro (Fig. 9 F). Of note, also in 
Numb-KO tumor cells, activation of the EMT program could be 
reverted by ectopically expressed Numb-DsRed (Fig. 9 F) or by 
treatment with Nutlin3 (Fig. 9 G).
Tumorigenesis by loss of Numb is 
p53 dependent
Impairment of p53 activity might be the mechanism responsible 
for the tumorigenic properties of Numb-KO MECs, a pheno-
type revertible, in principle, by Nutlin3. To test this, we selected 
the tumorigenic KO1 MEC line. Initially, we verified that the 
tumorigenicity of these cells was Numb dependent. Indeed, the 
ectopic expression of Numb-DsRed caused (a) restoration of 
p53 levels and function (Fig. 9 F), (b) decrease in SFE and MS 
size (Fig. 10 A), (c) reversion from symmetric to asymmetric 
Figure 6. Nutlin rescues the effect of Numb loss. (A) Ctr and Numb-KD MS were treated with Nutlin3 followed by IB. (B) Sphere number (left) and size 
(right) of Ctr and Numb-KD MS in the presence of Nutlin3. *, P < 0.05 versus mock treatment. (C) Cumulative sphere number from serial replating of Ctr 
and Numb-KD MS in the presence of Nutlin3. A single representative experiment out of two repeats is shown. (D) Mode of the first division of Numb-KD 
MS-initiating cells in the absence (Ctr) or presence of 10 µM Nutlin3 (Nutlin) as obtained from time-lapse experiments. *, P < 0.05 versus matching 
mode of division in Ctr.
 o
n






Published November 23, 2015
Numb/p53 in mammary stem cells • Tosoni et al. 853
Figure 7. Role of Numb in progenitors and differentiated cells. (A, left) Representative FACS analysis performed on Lin−/EPC AM+ MECs using CD49F 
and CD61 to resolve the basal, immature progenitor, and luminal differentiated subsets. The boxes show the gating strategies used to obtain the fractions. 
(right) Gating strategy to discriminate EpCAM+ cells (top); (bottom) flow cytometry dot plot with boxes showing CD61+ and CD49F+ events back-gated 
on the EpCAM plot. (B) Proportion of the three fractions, isolated as in A, in WT versus Numb-KO glands. Data are the mean of the percentage of each 
fraction relative to the bulk population of EPC AM+ cells calculated independently in three WT and five Numb-KO mice. Error bars are 95% confidence 
intervals (see Materials and methods). *, P < 0.05 versus matching fraction in WT. (C) The three fractions were silenced for Numb (KD) or mock-silenced 
(Ctr) and subjected to an MS assay. A typical assay is shown reporting the cumulative sphere (top) and cell (bottom) number upon serial replating. 
(D) Mammary outgrowths, generated in 3D-Matrigel cultures from the different Ctr and KD MEC fractions were transplanted into NOD/SCID mice. The fre-
quencies of SCs or cancer-initiating cells are shown, together with 95% confidence intervals. In all the cases, the Numb-KD MEC subfractions yielded tumors. 
(E) 3D-Matrigel outgrowths by Ctr or KD MEC fractions. In Ctr, basal cells formed typical filled structures (the organotypic ability in this fraction resides in the 
SC population), whereas progenitors formed hollow structures, and differentiated luminal cells displayed no organotypic ability but grew as bidimensional 
colonies or as small “filled” structures (diameter < 30 µm). In KD, luminal progenitors formed mainly filled-type structures (arrowhead in the middle panel), 
whereas differentiated luminal cells displayed de novo acquisition of organogenetic ability, with formation of both hollow and filled structures (Fig. S4 B). 
Bars, 100 µm. (F) Quantification of the experiment shown in E. Left, total number of outgrowths (acini) per 5,000 cells seeded. Data are the mean ± SD of 
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division (Fig.  9  B), and (d) reduction in tumorigenesis 
(Fig. 10 C). Cell proliferation or apoptosis of the bulk tumor 
population were not affected, suggesting a selective action of 
Numb on the intrinsic SC content (Fig. 10 D).
Next, cells dissociated from first-generation KO1 MSs 
were treated in vitro with Nutlin3. This caused (1) restoration 
of p53 levels and function (Fig. 9 G), (2) reduction in the num-
ber and size of MSs (Fig. 10 E), (3) increase in the frequency 
of SC asymmetric divisions (Fig.  10 F), and (4) reduction in 
tumorigenesis (Fig. 10 G). In a more stringent assay, we trans-
planted untreated KO1 cells and allowed tumors to reach a 
palpable size (∼40 mm3) before administering Nutlin3 in vivo. 
During this in vivo treatment, tumors in Nutlin3-treated mice 
continued to expand at the same rate as tumors in mock-treated 
mice (Fig. 10 H); however, upon retransplantation (in the ab-
sence of any further drug treatment), they displayed a decreased 
growth rate (∼50%) with respect to tumors from mock-treated 
animals (Fig.  10  I), despite no evident effects on bulk tumor 
cell proliferation or apoptosis (Fig. 10 J). Of note, the SFE of 
tumor cells derived from Nutlin3-treated animals was similarly 
decreased compared with mock-treated animals (Fig. 10 K). To-
gether, these results argue that restoration of the proficiency of 
the Numb/p53 circuitry yields a selective anticancer SC effect.
Discussion
Here, we demonstrate that Numb dysfunction contributes to 
mammary tumorigenesis by favoring the expansion of a pool 
of cells with stemness traits and intrinsic tumorigenic potential, 
operationally identifiable as cancer SCs. The biological and mo-
lecular bases of these phenotypes were dissected in an ex vivo 
setting in which cells displaying characteristics of SCs (PKH-
high cells) divide asymmetrically, giving raise to progeny with 
different fates (Cicalese et al., 2009; Pece et al., 2010). Under 
these conditions, the ability of Numb to safeguard against the 
emergence of cancer stem cells (CSCs) is apparently caused by 
a dual level of action: in the PKHhigh cell and in progenitors.
At the first mitosis of the PKHhigh cell, Numb is parti-
tioned into the DC that retains SC characteristics and imposes 
an asymmetric outcome to the self-renewing division, which 
prevents uncontrolled expansion. At present, we do not know 
whether Numb is asymmetrically partitioned in authentic SCs 
in vivo and whether this controls asymmetric divisional fate in 
the mammary gland. We have identified a population of Numb+ 
cells in the basal layer in vivo, in which Numb is apparently 
asymmetrically segregated at mitosis. It remains to be estab-
lished whether these cells are indeed SCs and, if so, whether the 
function of Numb in these cells is superimposable to the one 
that we characterized in the ex vivo setting.
In this latter setting, the action of Numb is mediated 
through regulation of the activity of p53. We showed that p53 
activity is comparably segregated between the two DCs of a 
PKHhigh cell but that it reaccumulates in the DC that retains 
stem-like features, though not in the progenitor. Because Numb 
inhibits p53 degradation (Colaluca et al., 2008), this argues 
that Numb stabilizes p53 in the stem-like DC. As a proof of 
this concept, we demonstrated that (a) in the absence of Numb, 
p53 activity is strongly decreased in the SC and in its progeny; 
(b) in the absence of Numb, the asymmetric reaccumulation of 
p53 activity in the stem-like DC does not occur; (c) the Numb 
KO phenocopies the p53 KO; and (d) the relevant phenotypes of 
Numb KO can be rescued by restoration of p53 activity.
The homeostatic function of the Numb-p53 axis might 
simply be the result of the growth-suppressive ability of p53, 
which could contribute to the stem-like DC withdrawal into 
quiescence: a hallmark of stemness. However, whereas Numb 
(this paper) and p53 (Cicalese et al., 2009) clearly impose an al-
ternative differentiative and proliferative fate on the progeny of 
PKHhigh cells, it is less clear how subversion of the Numb-p53 
circuitry influences the identity of the two DCs. The interpreta-
tion of the results here is not straightforward, as the two DCs 
display mixed stem (self-renewal) and progenitor (sustained 
proliferation) properties as an integral part of a tumorigenic 
phenotype. In the normal setting, at least in vitro, the mitotic 
retention of Numb clearly distinguishes, by the end of the 
PKHhigh cell self-renewing division, the stem-like DC from the 
progenitor-DC, although we did not establish whether the low 
Numb levels in the progenitor-DC are associated with a basal 
versus luminal identity. However, the progressive increase in 
Numb expression in transiently amplifying progenitors, as re-
capitulated in the early stages of MS formation in vitro, and the 
observation that Numb is a luminal layer marker in the adult 
gland, suggest an additional role for Numb, and of p53, in lu-
minal progenitors and luminal differentiated cells. Here, in the 
ex vivo setting, Numb appears to be critical for immature pro-
genitor differentiation, and its loss causes phenotypic plasticity 
and ectopic self-renewal ability at various stages of progenitor 
maturation, in association with the activation of the EMT.
We did not establish whether the molecular workings of 
Numb are different in the PKHhigh cell and in progenitors. How-
ever, in our ex vivo analyses, ablation of Numb resulted in sim-
ilar phenotypes when performed in a population of basal cells 
enriched in SCs or in progenitors, i.e., acquisition of cancer SC 
traits associated with the EMT, in a manner dependent on the 
downmodulation of p53. Thus, it is possible that the presence 
of Numb constitutes a tumor-suppressor barrier that acts, with 
similar molecular mechanisms, at two different cellular levels.
Consistent with this dual role established in vitro, the mam-
mary glands of Numb-KO mice displayed amplification of the 
SC pool accompanied by EMT and failure to coordinate correctly 
mammary gland morphogenesis, as witnessed by the formation 
of dysmorphic and/or overtly neoplastic mammary tissue. We do 
not know whether dysfunction of the Numb/p53 axis is the sole 
mechanism responsible for all these phenotypes. We note that 
loss of Numb expression also causes unchecked Notch activity, 
an event relevant to the transformed phenotype of Numb-deficient 
human tumors (Pece et al., 2004; Colaluca et al., 2008; Westhoff 
biological triplicates. *, P < 0.05 versus Ctr in each subpopulation. Right, type of acini formed. *, P < 0.05 versus Ctr in the matching (acini w/o or with 
lumen) condition. (G) The three MEC fractions, isolated as in A, were silenced for Numb (KD) or mock-silenced (Ctr) and analyzed by quantitative PCR. Data 
are from a single experiment run in triplicate and expressed relative to mRNA levels in Ctr cells (=1). E-Cad, E-cadherin (in basal cells, E-cadherin was not 
detectable [ND]). *, P < 0.05 versus Ctr. (H) MEC fractions, isolated as in A and silenced for Numb (KD) or mock-silenced (Ctr), were analyzed by IF for 
the expression of Sox9 and Slug (images are in Fig. S4 C). The percentage of Slug+ cells (left) and the mean intensity, expressed as arbitrary units (a.u.), 
of Sox9 (right) in the MEC fractions is displayed (>100 cells counted in four independent fields from a single experiment).
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Figure 8. Numb loss associates with aberrant morphogenesis and EMT in vivo. (A) Morphology of colonies (acini), formed in 3D-Matrigel by WT and 
Numb-KO MECs. (left) Images of the 3D colonies in Matrigel. Bar, 100 µm. (right) Quantification of colonies with/without lumen. *, P < 0.05 versus WT. 
(B) Hematoxylin and eosin (H&E) staining of FFPE sections from 3D-Matrigel colonies showing the hollow-type versus the filled-type morphology of WT 
(top) and Numb-KO (bottom) outgrowths. Bar, 100 µm. (C) Carmine-stained whole-mounts of 12-wk-old mammary glands of virgin WT or Numb-KO mice. 
The boxed areas are magnified on the right. In the KO magnification panel, the arrowhead in the inset points to an area of HAN. Bar, 3.5 mm. (D) H&E 
staining of FFPE mammary glands of WT and Numb-KO mice. The black and red arrowheads point to an enlarged duct and an area of HAN, respectively. 
Bar, 50 µm. (E) Relative number of primary ducts, relative ductal diameter, and relative number of secondary and tertiary branches per mammary gland of 
Numb-KO and WT mice, expressed as % relative to WT. Data represent mean ± SD of three independent sets (five mice/each genotype). *, P < 0.05 versus 
WT. (F, left) Multichannel IF analysis of FFPE mammary glands of WT (top) or Numb-KO (bottom). Boxed areas are magnified on the right. In the Numb-KO 
glands, the arrowheads in the insets point to double CK14+/CK8+ cells. CK8, green; CK14, red; DAPI, blue. Bars: (main) 50 µm; (insets) 10 µm. (right) 
Percentage of single- and double-positive cells in WT and Numb-KO glands. Note the difference between double CK8+/CK14+ cells in WT (<1%) and 
Numb-KO glands (∼5%). Data are from the analysis of >100 cells from a single experiment. (G) IF (left, E-cadherin) and IHC (middle, Slug, Sox9) analysis 
of FFPE sections from WT or Numb-KO glands. In the E-cadherin staining, the boxed areas are magnified at the bottom. Bars: (main) 50 µm; (insets) 10 µm. 
In the Slug/Sox9 images, the red arrowheads point to cells with concomitant Slug and Sox9 expression detected in 3-µm-thick serial FFPE sections of a 
Numb-KO gland. (right) WT and Numb-KO MECs were analyzed by quantitative PCR. Data are from a single experiment run in triplicate and expressed 
relative to mRNA levels in WT cells (=1). Vim., vimentin; Ecad., E-cadherin.
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et al., 2009). Thus, deregulation of Notch activity might consti-
tute an important factor, as also strongly suggested by evidence 
implicating Notch in the regulation of mammary SC self-renewal 
and in the proliferative/differentiative balance in progenitors 
(Weijzen et al., 2002; Raouf et al., 2008). In addition, our results 
indicate a gradient of alterations induced by Numb KO, from ab-
errant morphogenesis to preneoplastic lesions to various degrees 
of aggressiveness and tumorigenicity upon orthotopic transplan-
tation. However, the Numb-KO mice did not develop frank tu-
mors. This suggests the need for additional events to develop the 
fully transformed phenotype. The fact that epithelial cells from 
the KO gland were tumorigenic after reimplantation into the 
cleared fat pad of mice suggests that stromal components of the 
normal gland (or the architecture itself of the gland) might some-
how suppress the development of a fully transformed phenotype.
In conclusion, our data argue that the Numb/p53 circuitry 
is a potent tumor-suppressor barrier against the appearance 
of CSCs. Therefore, Numb- or p53-targeted therapies should 
constitute SC-specific treatments in tumors displaying loss of 
Numb. This would be relevant to naturally occurring cancer, 
because in human breast cancers, one third of all tumors are 
Numb deficient (Pece et al., 2004; Colaluca et al., 2008). We 
demonstrated the proof of mechanism for such an approach by 
restoring p53 levels in vivo, with Nutlin3, in a Numb geneti-
cally null background. Under these conditions, the drug was 
ineffective on the growth of the primary tumor while being 
efficacious in dampening, in the absence of any further expo-
sure to the drug, the growth of second-generation tumor trans-
plants, a result compatible with what would be expected of a 
targeted anti-CSC therapy.
Figure 9. Loss of Numb is tumorigenic. (A) MECs or dissociated MSs (Source) derived from the indicated genotypes (Genot.) were orthotopically trans-
planted into immunocompromised mice. The frequencies of SCs or cancer-initiating cells are shown, together with 95% confidence intervals. KO1 is repre-
sentative of the lines that gave rise to tumors; KO2 is representative of the lines that gave rise to aberrant mammary glands with areas of frank malignancy. 
(B, top) Data from A were recalculated after estimation of the total number of cells in the mammary gland/mouse, performed by digesting the pooled 
mammary tissues of individual mice and counting the cells. (bottom) The same calculations are reported for MS obtained from the indicated genotypes. 
(C, top and middle) Carmine-stained whole-mounts of outgrowths from WT or KO2 cells. The right panels show magnifications of the boxed areas (arrow-
heads and inset in KO2 images show an area of HAN). Bar, 3.5 mm. (bottom) A KO1-induced tumor is shown (left) with its histological appearance (right). 
Bar, 100 µm. (D) H&E staining of FFPE tissues from outgrowths generated by WT or KO2 MECs. Bar, 50 µm. (E) Left, IHC analysis of serial FFPE sections 
from a retransplanted KO1 tumor (top, KO1) or from a WT gland (bottom, WT). ER, estrogen receptor; E-Cadh., E-cadherin. Bar, 50 µm. Right, IHC analysis 
of serial FFPE sections from a retransplanted KO1 tumor. The magnified insets help visualizing Slug+ and Sox9+ cells. Bar, 50 µm. (F and G) Numb-KO1 
cells were transduced with Numb-DsRed (KO1+Numb in F) or treated with 10 µM Nutlin3 (KO1+Nutlin in G), and compared with mock-infected (KO1 
in F) or vehicle-treated (KO1 in G) cells, by IB. N-Cad, N-cadherin; Fibron., fibronectin. The red and black arrowheads (in F) indicate the overexpressed 
Numb-DsRed and the endogenous Numb proteins, respectively. The two IBs in F were loaded with the same lysates.
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Materials and methods
Cell biology procedures and flow cytometry
Primary MECs were isolated from murine tissues and cultivated in 
suspension to yield first- (F1) or second-generation (F2) MSs, as de-
scribed previously (Cicalese et al., 2009; Pece et al., 2010; Tosoni et al., 
2012). In brief, murine mammary glands from FVB WT or Numb-KO 
mice were mechanically dissociated and digested in DMEM/F12 
medium supplemented with 1 mM glutamine, 200 U/ml collagenase 
(Sigma-Aldrich), and 100 U/ml hyaluronidase (Sigma-Aldrich) at 
37°C for 4 h. Cell suspensions were then centrifuged (80 g, 5 min), 
resuspended in 0.2% NaCl to lyse red blood cells, and sequentially fil-
tered through membrane syringe filters of decreasing pore sizes (100-, 
70-, 40-, and 20-µm meshes). Resulting cells were plated onto ultralow 
attachment plates (Falcon) at a density of 100,000 viable cells/ml (to 
obtain primary MS) in a stem cell medium (SCM) composed of se-
rum-free mammary epithelial basal medium (Clonetics) supplemented 
with 5 µg/ml insulin, 0.5 µg/ml hydrocortisone, B27 (Invitrogen), 
Figure 10. Restoration of the Numb/p53 axis in Numb-deficient cells. (A–D) SFE and MS size (A), mode of division (B), and tumorigenicity (C) of KO1 
cells and KO1 cells transduced with Numb-DsRed (KO1+Nb). Protein levels for this experiment are shown in Fig. 9 F. *, P < 0.05 versus KO1 in the match-
ing condition. Tumors from KO1 cells or from KO1 cells transduced with Numb-DsRed (KO1 + Nb) were analyzed by IHC as indicated (D); the percentage 
of positive cells is shown (>30,000 cells counted). The “Epifluorescence” panel shows the expression of Numb-DsRed in the KO1+Nb tumors. Bar, 100 µm. 
(E–G) SFE and MS size (E), mode of division (F), and tumorigenicity (G) of KO1 cells treated in vitro with 10 µM Nutlin3 or vehicle (Ctr). Protein levels for 
this experiment are shown in Fig. 9 G. *, P < 0.05 versus Ctr. (H) KO1 cells were orthotopically transplanted into immunocompromised mice and allowed 
to form tumors of ∼40 mm3 (dashed red line) before treatment with Nutlin3 or mock treatment (Ctr). At the end of the experiment, tumor size was measured. 
(I–K) Cells dissociated from tumors described in H were either retransplanted orthotopically in mice and left to grow for 3 wk (I) and analyzed by IHC (J) 
or tested for MS formation (K). *, P < 0.05 versus Ctr.
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20 ng/ml EGF and bFGF (BD Biosciences), and 4 µg/ml heparin 
(Sigma-Aldrich). MS were collected after 6 d and mechanically dis-
sociated by pipetting up and down several times with a fire-polished 
pipette to yield a single cell suspension. For serial MS propagation ex-
periments, 5,000 cells derived from dissociation of primary MS were 
plated in quadruplicate in nonadherent conditions in SCM (liquid sus-
pension culture) using 24-multiwell plates coated with a Poly HEMA 
(Sigma-Aldrich) solution (1.2% in 95% ethanol) or in SCM containing 
1% methyl-cellulose. After 7 d, secondary MSs were counted and then 
dissociated to calculate the SFE (total number of MSs/total number of 
plated cells × 100). The same procedure was repeated to obtain subse-
quent MS generations over at least three more passages.
PKH labeling of MS was with PKH26 or PKH2-GL (PKH488) 
dyes (Sigma-Aldrich). Single-cell suspensions, from dissociated 
PKH-labeled MS, were FACS-sorted using a FACS Vantage SE 
flow cytometer (BD) equipped with a 488 nm laser (Enterprise Co-
herent) and a band-pass 575/26 nm optical filter (FL2 channel). A 
mean sorting rate of 1,000 events per second at a sorting pressure 
of 20 PSI was maintained.
For the purification of basal, progenitor, and terminally differ-
entiated cells, single-cell suspensions, from mammary glands of 4- to 
6-wk-old virgin mice, were lineage depleted with a cocktail of bioti-
nylated antibodies (Abs) against CD5, CD45R, CD11b, GR-1 (Ly-
6G/C), 7–4, and Ter-119 (Lineage Cell Depletion kit, #130-090-858; 
Miltenyi Biotec) and then FACS sorted using Abs against EpCAM 
(APC-conjugated 4G8.8 rat IgG2a; eBioscience), CD61 (FITC-conju-
gated hamster IgG1), and CD49F (PE-conjugated rat IgG2a) from BD 
Biosciences. Unstained cells were used as a negative control to establish 
the background fluorescence. To adjust the compensation, single stained 
Ctr cells were used for each dye used. Gating was initially applied to 
isolate single cell populations of viable cells, then additional gating was 
used to select for the bulk EpCAM+ population. EpCAM+ cells were 
then analyzed for the expression of CD61 and CD49F to resolve the 
different subsets of basal/myoepithelial (EpCAM+/CD49Fhigh/CD61+ 
cells), immature luminal progenitors (EpCAM+/CD49Flow/CD61+) and 
luminal differentiated (EpCAM+/CD49Flow/CD61−) cells. Flow cyto-
metric analysis was performed using Kaluza Flow Analysis Software 
(Beckman Coulter). The purified MEC subfractions were infected with 
the silencing vector for Numb (see following paragraph) and used for 
MS propagation assays or for 3D-Matrigel organotypic cultures.
3D-Matrigel organotypic cultures were performed as previously 
described (Asselin-Labat et al., 2007; Guo et al., 2012), with minor 
modifications. In brief, single-cell suspensions from bulk MECs 
(∼5,000 cells/well) or from FACS-purified MEC subfractions (∼2,000 
cells/well) were seeded in Poly-HEMA-coated four-well glass cham-
ber slides (Chamber Slide System, 154526; Nunc) in a total volume 
of 700 µl mammary epithelial basal medium containing 5% Matrigel 
growth factor–reduced basement membrane matrix (354234; BD), 
supplemented with 2% heat-inactivated FBS, 10 ng/ml EGF, 20 ng/
ml bFGF, 4 µg/ml heparin, and 2% B27. Cells were incubated at 37°C 
in the presence of 5% CO2 for 14 d, with 300 µl fresh medium added 
every 7 d. The number of organotypic structures was counted 7–14 d 
after seeding. Resulting organotypic structures were observed and pho-
tographed using an inverted phase-contrast microscope equipped with 
a digital camera. To better visualize hollow- and filled-type structures, 
the organotypic outgrowths were fixed in 4% PFA for 1 h, stained with 
DAPI, and subjected to confocal analysis. When using 3D-Matrigel 
outgrowths for transplantation studies, the organotypic structures em-
bedded in Matrigel were recovered by adding at each well of the cham-
ber slide 1 ml ice-cold MatriSperse Cell Recovery Solution (354253; 
BD). After 1 h incubation on ice, the gel layers containing the struc-
tures were scraped and collected in a tube, rinsed with 1 ml BD Cell 
Recovery Solution, and incubated again for 30 min on ice and then cen-
trifuged. The pellet containing the structures was washed with PBS and 
further digested with 0.05% trypsin for 10–15 min. The digested cells 
were then filtered through 40-µm cell strainers to obtain single cells. 
The cells were then counted, resuspended in ice-cold 1:1 PBS/phenol 
red-free growth-factor reduced Matrigel solution, and immediately 
transplanted into the mammary fat pad of immunocompromised mice.
Methodologies for the retrospective assignment of the cellular identity
The methodology used to retrospectively assign cellular identity and 
mode of division is illustrated in Fig. 1 C. Single-cell suspensions ob-
tained from mammary glands were cultured in nonadherent conditions, 
as described above (Cicalese et al., 2009; Pece et al., 2010; Tosoni et 
al., 2012). Under these conditions, as shown in Fig. 1 C.1, most cells 
did not proliferate or underwent anoikis (represented by dashed cir-
cles), whereas SCs gave rise to MSs (represented by clusters of solid 
circles). MSs were then isolated and dissociated, infected with appro-
priate expression vectors, if needed, and stained with PKH dyes (dark 
green circles in Fig. 1 C.2). Cells were then replated in methylcellulose 
to allow the formation of second-generation MSs. The formation of 
MSs was monitored for up to 168 h by video microscopy. The modality 
of the first mitotic division was established by two criteria: the pattern 
of cell number progression within the forming MS (Fig. 1 C.3.1) and 
pattern of PKH labeling in the forming MS (Fig. 1 C.3.2).
When determining the modality of division based on cell number 
progression (Fig. 1 C.3.1), a 1-2-3-5 pattern of cell number progression 
was considered as the result of an initial asymmetric division, followed 
by symmetric divisions of the progenitors (see Fig. 1 D for actual im-
ages). Conversely, a 1-2-4 progression pattern was the result of an ini-
tial symmetric division. In this case, after the four-cell stage, the exact 
number of cells cannot be unequivocally determined in the absence of a 
precise 3D reconstruction. Therefore, we used 6/8 in Fig. 4 E and Fig. 
S2 E to indicate the number of cells originated after the four-cell stage.
When determining the modality of division based on the pattern 
of PKH labeling in the forming MS (Fig. 1 C.3.2), we reasoned that an 
asymmetric division would yield a stem-like DC that remains quiescent 
and therefore retains the PKH dye, whereas the progenitor-DC would 
divide further to yield several dull precursors. In such cases, the stem-
like DC can be retrospectively identified based on intensity of PKH la-
beling. A schematic representation of this type of PKH staining pattern 
within a secondary MS is shown in panel 3.2 of Fig. 1 C.
Of note, we found that most cells from the primary MS (the pro-
genitors) did not give rise to secondary MS, or generated only small 
spheroids (up to 30 cells), which were not considered in the analyses 
shown in the main text (depicted here as dashed, filled green circles in 
Fig. 1 C.3.2). Thus, only spheroids, equal or larger than 70 µM, were 
considered as MS and analyzed retrospectively in the time-lapse movies.
The methodology depicted in Fig. 1 C.3.1 was used in all anal-
yses (Figs. 1 D, 4 E, 6 D, and 10, B and F; and Figs. S1 F and S2 F); 
in some experiments (those depicted in Figs. 1 D and 5, B, D, and E; 
and Fig. S1 F) the methodology depicted in Fig. 1 C.3.2 was used as 
an additional criterion.
Antibodies and reagents
Primary Abs for immunofluorescence (IF) were directed against: p53 
(DO-1, mouse monoclonal), Sox-9 (H-90, rabbit polyclonal), CD49F 
(C-18, rabbit polyclonal; Santa Cruz Biotechnology); Numb (AB21, 
a mouse monoclonal Ab against amino acids 537–551 of hNumb [Co-
laluca et al., 2008] or Cell Signaling Technologies [C29G11, rabbit 
monoclonal]); γ-tubulin (Cy3-conjugated rabbit polyclonal, C7604; 
Sigma-Aldrich); phospho-histone 3 (PH3, mouse monoclonal, 14955; 
Abcam; rabbit polyclonal, 06–570; Millipore); CK8 (TRO MA1, rat 
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monoclonal; produced in-house); p63 (DAK-p63, mouse monoclonal; 
Dako); E-cadherin (24E10, rabbit monoclonal), Slug (C19G7, rabbit 
monoclonal; Cell Signaling Technologies); and CK14 (AF64, rabbit 
polyclonal; Covance). Fluorochrome-conjugated secondary Abs were 
obtained from Jackson ImmunoResearch Laboratories.
Abs for immunohistochemistry (IHC) were directed against 
Ki-67 (SP6, rabbit monoclonal; Thermo Fisher Scientific); activated 
caspase-3 (Asp175, rabbit polyclonal, Cell Signaling Technologies); 
CK18 (C-04, mouse monoclonal; Santa Cruz Biotechnology); and 
CK14, Slug, Sox-9, and Numb (same as for IF).
Abs for immunoblot (IB) were directed against: vinculin (mouse 
monoclonal; Sigma-Aldrich), p53 (1C12, mouse monoclonal; Cell Sig-
naling Technologies); p21 (F-5, mouse monoclonal; Santa Cruz Bio-
technology); Sox-9 (AB5535, rabbit polyclonal; Millipore); GRP94 
(9E10, rat monoclonal, Enzo Life Sciences); N-cadherin, β-catenin 
(mouse monoclonal; BD Biosciences); Fibronectin (ab299, rabbit poly-
clonal; Abcam); and Ki-67, Numb, Slug, and activated caspase-3 (same 
as for IF or IHC). In the IB experiment shown in Fig. S3 B, the panels 
were assembled from different lanes of the same blot by splicing out 
lanes loaded with additional Ctrs (indicated by a thin line). In all IB, 
vinculin and/or GRP94 were used as loading Ctrs.
Nutlin3 was purchased from Cayman Chemical or supplied by 
S.  Minucci and M.  Varasi (European Institute of Oncology, Milan, 
Italy). Cisplatin was obtained from TEVA ITA LIA; the (+)-enantiomer 
Nutlin3b was obtained from Cayman Chemical, MG132 was obtained 
from Enzo Life Science, and methylcellulose (MethoCult SF M3236) 
was obtained from StemCell Technologies.
Treatment with Nutlin3
The concentration of Nutlin3 to be used in the in vitro experiments 
was established based on the data shown in Fig. 6 A and Fig. S3 B. A 
concentration of 10 µM Nutlin3 was sufficient to restore p53 levels and 
activity in the absence of any effect on cell proliferation and apopto-
sis, assessed by Ki-67 and activated caspase-3 levels, respectively (see 
Fig.  10  J for similar results obtained by IHC). A minimal effect on 
apoptosis, but not on proliferation, was observed at 20  µM Nutlin3, 
whereas 30 µM Nutlin3 caused a significant inhibition of cell prolifer-
ation and induction of apoptosis. Based on these results, a concentra-
tion of 10 µM Nutlin3 was selected to perform the described in vitro 
experiments. An inactive enantiomer of Nutlin3, Nutlin3b, was used as 
an additional control to check for potential off-target effects; Nutlin3b 
was inactive in all experiments at concentrations five times higher than 
the concentration of Nutlin3 used (Fig. S3, C and D).
For the in vivo experiments, we tailored the administration reg-
imen (20 mg/kg injected intraperitoneally every 3 d for a total of 12 
d/four treatments) to minimize the apoptotic and necrotic effects re-
ported to be associated with higher concentrations of Nutlin3 and/or 
more prolonged exposure to this drug (Künkele et al., 2012). In this re-
gard, we note that our Nutlin3 administration protocol did not affect the 
initial growth rate of the primary transplants (Fig. 10 H) or apoptosis 
(Fig. 10 J), a finding in keeping with reports demonstrating minimal, if 
any, antitumor effects of short-term (1–2 wk) Nutlin3 treatments (Tovar 
et al., 2006; Vaseva et al., 2011; Künkele et al., 2012).
Engineering of vectors and quantitative PCR
The lentiviral GFP reporter vector pTRH1-p53-dscGFP (TR502PA-1, 
System Biosciences), expressing an unstable GFP variant (uGFP; half-
life of ∼60 min) under the control of four tandem copies of a p53-binding 
site upstream of a minimal CMV promoter, was used to monitor p53 ac-
tivity. Cells from dissociated MSs were lentivirally transduced in suspen-
sion and allowed to form next-generation MSs for 7 d. Cells were then 
PKH-labeled and used for time-lapse video microscopy experiments.
The lentiviral construct harboring the Numb-DsRed fusion pro-
tein was engineered by subcloning into the pLVX puro lentiviral vec-
tor (Rubinson et al., 2003) the Numb cDNA (provided by J.M. Verdi, 
Maine Medical Center Research Institute, Scarborough, ME) in frame 
with the DsRed (from the pDsRed-Monomer-N1 vector; Clontech).
The mCMV-Numb-DsRed lentiviral construct, used in the ex-
periments in Fig. 3 A and Fig. S1 (G and H), and expressing Numb-
DsRed under the control of a CMV minimal promoter, was obtained 
eliminating the first 668 bases of the CMV promoter of the pLVX-puro/
Numb-DsRed construct by PCR-based site-directed mutagenesis. The 
following oligos were used to yield the minimal CMV promoter se-
quence: forward, 5′-GAC GCAAA TGGGC GGTAG GCGTG TACGG-
3′; reverse, 5′-ATC GATAA ACTGG ATCTC TGCTG TCCCTG-3′ 
(5′-GAC GCAAA TGGGC GGTAG GCGTG TACGG TGGGA GGTCT 
ATATA AGCAG AGCTG GTTTA GTGAA CCGTC AGATC-3′). The 
construct was sequence verified.
Quantitative RT-PCR analysis was performed using the TaqMan 
Cells-to-CT kit (Ambion). Each sample was tested in triplicate. The ΔCt 
method was used to calculate the mRNA levels of each target gene nor-
malized against two different housekeeping genes. The ΔΔCt method 
was used to compare the mRNA levels of each target gene, normalized to 
the housekeeping genes, relative to an external standard. Taqman Gene 
Expression Assay IDs (Applied Biosystems) were Mm00432448-m1 
(p21, NM_007669), Mm00487656-m1 (mdm2, NM_010786.3), 
Mm02384862-g1 (nanog, NM_028016.1), Mm00468601-m1 
(hes1, NM_008235), Mm00468865-m1 (hey1, NM_010423.2), 
Mm00469280-m1 (hey2, NM_013904.1), Mm00441533-g1 
(snai1, NM_011427.2), Mm00441531-m1 (snai2, NM_011415.2), 
Mm00442036-m1 (twist1, NM_011658.2), Mm00486906-m1 
(cdh1, NM_009864.2), Mm00483213-m1 (cdh2, NM_007664.4), 
Mm01333430-m1 (vimentin, NM_011701.4), Mm00448840-m1 
(sox9, NM_011448.4), Mm00477927-m1 (numb, NM_001136075.2), 
Mm00495564-m1 (zeb1, NM_011546.2), Mm99999915-g1 (GAP 
DH), and Mm00437762-m1 (β2-microglobulin).
shRNA experiments
shRNA lentiviral vectors, used to abrogate Numb expression, 
were obtained from System Biosciences (pLKO-Numb vectors): 
TRCN0000105735 (sh-a in Fig. S2 A; hairpin sequence: 5′-CCGG-GCA 
GCCTG TTTAG AGCGT AAA-CTC GAG-TTT ACGCT CTAAA CAGGC 
TGC-TTT TTG-3′) and TRCN0000105739 (sh-b in Fig. S2 A; hairpin 
sequence: 5′-CCGG-CAG CAGAC ATTCC CTCAA TAT-CTC GAG-ATA 
TTGAG GGAAT GTCTG CTG-TTT TTG-3′). Cells from dissociated MS 
were lentivirally transduced in suspension and allowed to form next gen-
eration MS for 7 d under puromycin selection. In all KD experiments, Ctr 
populations were always transduced with a Ctr shRNA-Luciferase vector 
(pLKO-Luc, TRCN0000072243).
Two independent mass populations (KD1 and KD2) were de-
rived from cells silenced with sh-b (which reproducibly induced the 
best levels of silencing) and used for all the experiments shown in the 
main text. In some cases silencing (always with the oligo sh-b) was 
performed in immunophenotypically purified fractions of Numb-KD 
MECs (Fig.  7, C–H). In these cases, we refer to the silenced cells 
generically as Numb-KD.
Imaging studies
Time-lapse video microscopy was performed with a Scan^R screening 
station (Olympus-SIS) equipped with an Olympus IX 81 inverted mi-
croscope with a Hamamatsu Orca R2 Cooled CCD camera, an Olym-
pus MT20E illumination system and an incubation chamber (Evotec/
Okolab); images were acquired at 37°C with Scan^R/Xcellence soft-
ware. Cells from dissociated MS were resuspended in methylcellulose 
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in complete medium, plated onto glass-bottom dishes and observed 
through a 10× 0.4 NA air objective. Differential interference contrast, 
PKH-, GFP-, and DsRed-epifluorescence images were collected with 
autofocusing procedures and compensated for focal shift. Different 
focal planes were recorded to prevent loss of image contrast caused 
by axial cell movement. Images were captured every hour for 7 d, 
starting 16–18 h after plating, and reconstructed using ImageJ or Mat-
lab software (MathWorks).
Confocal analyses were performed with a Leica TCS SP5 AOBS 
microscope system equipped with Leica HyD (high-quantum-effi-
ciency hybrid detector) and PMT detectors. Images were acquired at 
37°C for live cells and 22°C for fixed samples using 10× 0.4 NA and 
20× 0.5 NA air objectives, or 40× 1.3 NA and 63× 1.4 NA oil-immer-
sion objectives under the control of LAS AF Software (Leica). For the 
IF analyses depicted in Fig. 2 (B and C), we used formalin-fixed par-
affin-embedded (FFPE) consecutive serial sections from 4-wk-old mu-
rine mammary glands. For each of the series shown, an initial section 
was stained with mouse anti-PH3 (14955; Abcam), rabbit anti-Numb 
(C29G11; Cell Signaling Technologies), and Cy3-conjugated rabbit 
anti-γ-tubulin (C7604; Sigma-Adrich) Abs and DAPI. After the acqui-
sition of the images, the same section was then processed by removing 
the coverslip, performing a new round of antigen retrieval, followed 
by staining with a rat anti-CK8 Ab (TRO MA1), a mouse anti-PH3 Ab, 
and DAPI. This procedure was repeated to perform a further round of 
staining of the same section with a mouse anti-PH3 and Cy3-conju-
gated rabbit anti–γ-tubulin Abs and DAPI. A consecutive serial section 
was stained with a mouse anti-p63 Ab (DAK-p63; Dako) and DAPI. 
Multiple focal planes were acquired for each channel to ensure that 
signals on different focal planes were included. Because the separated 
centrosomes within the same cells were often located in different focal 
planes, because of the thickness of the nucleus, we selected only those 
planes allowing visualization of centrosomes in the same focal plane. 
Merged images represent the projection on the plane of centrosomes of 
confocal optical z-section slices, showing optimal signals for Numb, 
γ-tubulin, and PH3, acquired in different stainings of the same section. 
Images were analyzed with tools available via ImageJ/Fiji software, for 
simultaneous processing of multiple z-stacks, and Photoshop (Adobe).
Mice and histological procedures
Numb-KO mice were generated by crossing Numblox/lox mice (Zilian 
et al., 2001; Wilson et al., 2007) with CK5-Cre mice (Ramirez et al., 
2004). Targeted deletion of the numb allele was confirmed by PCR 
genotyping, as described previously (Zilian et al., 2001; Ramirez et 
al., 2004). NOD/SCID-IL-2R gamma chain-null mice (The Jackson 
Laboratory) were used as recipient for transplantation experiments 
(Cicalese et al., 2009; Pece et al., 2010). Mouse colonies were main-
tained in a certified animal facility in accordance with national and 
institutional guidelines.
Mammary glands, from WT and Numb-KO female mice or from 
outgrowths, were processed for whole-mount analysis, as described 
previously (Cicalese et al., 2009). In brief, inguinal glands were ex-
cised and spread onto a clean 75 × 50-mm glass polysine microscope 
slide (Thermo Fisher Scientific) and fixed in a 3:1 glacial acetic acid/
ethanol solution at room temperature for at least 2  h or overnight. 
Tissues were then hydrated through 70% ethanol for at least 30 min, 
rinsed in distillated water twice for 10 min, and stained in carmine 
alum (Sigma-Aldrich) at RT overnight. Tissues were then dehydrated 
through a graded ethanol series (70–95–100%) for at least 30 min 
and finally clarified in a 1:2 benzyl alcohol/benzyl benzoate solution. 
Whole mounts were photographed using a stereomicroscope (Stereo 
Microscope SZX16; Olympus) equipped with a digital camera (Dig-
ital Sight DS-5Mc; Nikon) and acquisition software (NIS-Elements 
version 2.3; Nikon). HANs and infiltrating cancers were recognized 
and classified according to guidelines for the pathological evaluation 
of genetically engineered mice (Medina, 1988; Cardiff et al., 2000).
For IHC analysis, 3-µm-thick sections of FFPE mammary whole 
mounts or tumors were assayed with the appropriate Abs. Slides were 
digitally scanned with the Aperio ScanScope XT and automatically 
analyzed with the Aperio ImageScope IHC nuclear algorithm (Aperio 
Technologies). Areas containing 30–60,000 cells were analyzed, and 
the percentage of positive cells was calculated. Digital images were 
processed with Photoshop CS3.
Statistical analyses
Time-lapse video-microscopy experiments to monitor the mode (asym-
metric vs. symmetric) of division. In each experiment, we calculated 
the percentage of asymmetric (one SC → one SC + one P, progenitor) 
and symmetric (one SC → two SCs) divisions for each condition, as 
described above and illustrated in Fig.  1 C. For the experiments de-
picted in Figs. 4 E, 6 D, 10, B and F, and S2 F, results are reported as 
the percentage of asymmetric and symmetric divisions calculated for 
each group in at least three independent experiments, with the corre-
sponding standard deviations. The entire set of data was statistically 
analyzed using the nonparametric Fisher’s exact test. For the experi-
ments depicted in Fig. 1 D and Fig. S1 H, data were statistically ana-
lyzed using the one-sample z-test for proportions. A p-value <0.05 was 
considered as significant.
Time-lapse video microscopy experiments to assess the time of 
division. We analyzed at least three independent experiments. Results 
depicted in Fig. 4 E and Fig. S2 (E and F) report, for each WT/Ctr and 
Numb-KO/Numb-KD group, the mean value of the time of division and 
the standard error calculated in the three replicates. The nonparametric 
Kolmogorov-Smirnov test was used to analyze the distribution of data 
collected in the different groups. A p-value <0.05 was considered as 
significant.
Time-lapse video microscopy experiments to monitor p53 activ-
ity during mitosis. For the in vivo fluorescence analysis of p53 activity 
during the first mitotic division (Fig. 5, D and E), the mean intensity 
(GFP intensity) in the DCs (1 SC + 1 P, progeny in Ctr; 2 DCs, progeny 
in Numb/KD) at each time point was normalized to the corresponding 
mean intensity of the mother cell at mitosis. Lines that best approximate 
the time-point data up to the second mitotic division were obtained by 
linear regression analysis (best-fit lines, n = 13). The mean best fit was 
calculated, and the nonparametric Kolmogorov-Smirnov test was used 
to compare the distribution of data relative to the progeny of Ctr cells 
(SC and P), assuming a statistical significance level of P < 0.05.
Statistical analysis of other experiments. Experiments depicted 
in Fig.  1 (B and D); Fig.  3 (B and C); Fig.  4  E; Fig.  5 (A–C); Fig.  6 
(B and D); Fig.  7 (E and F); Fig.  10 (A, C, E–I, and K); Fig. S1 F; 
Fig. S2 F; and Fig. S3 (A, C, and D) were performed at least in biological 
triplicates, whereas experiments in Fig. 4 B; Fig. 7 (G and H); Fig. 8 (F 
and G); Fig. S2 B; and Fig. S4 (A and C–E) were performed at least in 
technical triplicates. Results are expressed as mean values, and error bars 
indicate standard deviations. A p-value of <0.05 was considered as signif-
icant. Experiments depicted in Fig. 7 (A and B) were analyzed using the 
Pearson’s χ2 test of independence. Error bars are 95% confidence intervals. 
A p-value of <0.05 was considered as significant. Experiments depicted 
in Fig. 2 (B–D) were analyzed using the Fisher’s exact test. Error bars 
are 95% confidence intervals. A p-value <0.05 was considered significant.
For transplantation studies, the frequencies were calculated by 
Poisson statistics, using the “StatMod” software package for the R com-
puting environment, as described previously (Shackleton et al., 2006) 
and a complementary log-log generalized linear model (two-sided 
95% Wald confidence intervals or, in case of zero outgrowths, one-
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sided 95% Clopper-Pearson intervals), respectively. The single-hit 
assumption was tested as recommended and was not rejected for any 
dilution series (P > 0.05).
Online supplemental material
Fig. S1 shows the procedure for the prospective isolation of 
PKHhigh cells from the mouse mammary gland and their functional 
characterization in vitro and in vivo as cells with intrinsic stemness 
traits, as opposed to PKHlow or PKHneg cells. Also shown is the 
divisional history of PKHhigh cells and the asymmetric distribution of 
Numb at their mitosis. Fig. S2 shows the effects of Numb ablation, 
through the use of two different shRNA lentiviral vectors, on selected 
p53 and Notch transcriptional targets. Also shown are the effects of 
Numb silencing on the formation and serial propagation of MSs and 
on the divisional history of mammosphere-forming cells in vitro. Fig. 
S3 shows the expression of p53 in PKHhigh versus PKHneg cells and 
the characterization of Nutlin3 as a pharmacological tool to revert 
the dysfunction of p53 caused by loss of Numb. Fig. S4 shows that 
loss of Numb triggers an EMT program in the mammary gland and 
associates with traits of faulty mammary morphogenesis in vitro and 
in vivo. Fig. S5 shows the effects of Numb ablation on the intrinsic 
content of cells in MSs, which display mammary repopulating 
activity in limiting dilution transplantation experiments. Also shown 
is the histological appearance of the mammary outgrowths generated 
by the orthotopic transplantation of Numb-silenced cells. Online 
supplemental material is available at http ://www .jcb .org /cgi /content 
/full /jcb .201505037 /DC1. Additional data are available in the JCB 
DataViewer at http ://dx.doi.org/10.1083 /jcb .201505037 .dv.
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